{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-033380","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2023-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.188932+00:00","generated_at":"2026-06-18T01:00:42.218427+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"JATT shareholders approve business combination with Zura Bio; closing expected March 20","bullets":["Shareholders voted 4,903,764 for (99.9% of votes cast) vs 4,099 against to adopt the Business Combination Agreement.","Closing expected on March 20, 2023; combined company to trade on Nasdaq as ZURA (shares) and ZURAW (warrants) starting March 21.","Holders of 4,907,863 ordinary shares (95.5% of outstanding) were present or represented at the March 16 extraordinary general meeting.","All other proposals – Charter amendments, director elections, equity plans – also approved by similar margins."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-033380","json":"https://secwatch.observer/filing/0001104659-23-033380.json","markdown":"https://secwatch.observer/filing/0001104659-23-033380.md","text":"https://secwatch.observer/filing/0001104659-23-033380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/tm239794d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T01:00:42.218427+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"222bef6211456e463b9e2a52322a09e51f2d7511","claim":"Zura Bio Ltd shareholders approved Binding Organizational Documents Proposal C: A proposal to adopt the second amended and restated memorandum and articles of association of the Company. at the 2023-03-16 meeting.","evidence_excerpt":"Binding Organizational Documents Proposal C: A proposal to adopt the second amended and restated memorandum and articles of association of the Company. The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,903,764 4,099 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"46bb2ec4cf2a5faadb63e5ff79bb71b16e34731c","claim":"Zura Bio Ltd shareholders approved Advisory Governance Proposal B: A proposal to require the removal of any director for cause or by the affirmative vote of at least two-thirds (662/3%) of the voting power of all then-outstanding shares of the Company entitled to vote thereon, voting together as a single class. at the 2023-03-16 meeting.","evidence_excerpt":"Advisory Governance Proposal B: A proposal to require the removal of any director for cause or by the affirmative vote of at least two-thirds (662∕3%) of the voting power of all then-outstanding shares of the Company entitled to vote thereon, voting together as a single class. The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,359,773 548,090 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"582bc9447050150e7226114b8700409cb920c029","claim":"Zura Bio Ltd shareholders approved Binding Organizational Documents Proposal A: A proposal to approve the change in authorized share capital of the Company to $30,100 divided into 300,000,000 Class A ordinary shares, no Class B ordinary shares, and 1,000,000 preference shares. at the 2023-03-16 meeting.","evidence_excerpt":"Binding Organizational Documents Proposal A: A proposal to approve the change in authorized share capital of the Company to $30,100 divided into 300,000,000 Class A ordinary shares, no Class B ordinary shares, and 1,000,000 preference shares. The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,903,764 4,099 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"68da8f987dcccdf5fad203421598e3b310840977","claim":"Zura Bio Ltd shareholders approved The Director Appointment Proposal: A proposal to elect, effective as of the consummation of the Business Combination, of Someit Sidhu, Amit Munshi, Sandeep Kulkarni, Garry Neil, Steve Schoch, Jennifer Jarrett and Neil Graham as directors and to serve on the Company's board until the expiration of th at the 2023-03-16 meeting.","evidence_excerpt":"The Director Appointment Proposal A proposal to elect, effective as of the consummation of the Business Combination, of Someit Sidhu, Amit Munshi, Sandeep Kulkarni, Garry Neil, Steve Schoch, Jennifer Jarrett and Neil Graham as directors and to serve on the Company's board until the expiration of their respective terms and until their respective successors are duly appointed and qualified. Someit Sidhu Votes For Votes Against Abstentions 4,903,764 4,099 0 Amit Munshi Votes For Votes Against Abstentions 4,903,764 4,099 0 Sandeep Kulkarni Votes For Votes Against Abstentions 4,903,764 4,099 0 Garry Neil Votes For Votes Against Abstentions 4,903,764 4,099 0 Steve Schoch Votes For Votes Against Abstentions 4,903,764 4,099 0 Jennifer Jarrett Votes For Votes Against Abstentions 4,903,764 4,099 0 Neil Graham Votes For Votes Against Abstentions 4,903,764 4,099 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"85d73bb4a7a53025f730c4e57727762f5e90cc7c","claim":"Zura Bio Ltd shareholders approved Advisory Governance Proposal C: A proposal to provide that the alteration, amendment or repeal of the Proposed MAA will require the affirmative vote of the holders of at least two-thirds (662/3%) of the voting power of the then-outstanding shares entitled to vote thereon, voting together as a single at the 2023-03-16 meeting.","evidence_excerpt":"Advisory Governance Proposal C: A proposal to provide that the alteration, amendment or repeal of the Proposed MAA will require the affirmative vote of the holders of at least two-thirds (662∕3%) of the voting power of the then-outstanding shares entitled to vote thereon, voting together as a single class. The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,903,764 4,099 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"9dc916e554b4a53f9444e9ee726fd04a7dfe143c","claim":"Zura Bio Ltd shareholders approved The Equity Plan Proposal at the 2023-03-16 meeting.","evidence_excerpt":"The Equity Plan Proposal The proposal to ap","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.8,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"a4c312dce7189a108a392968b3131674fc39cac4","claim":"Zura Bio Ltd shareholders approved Advisory Governance Proposal D: A proposal to provide that shareholders will not be permitted to act by written resolution in lieu of holding a meeting of shareholders; and to eliminate provisions specific to its status as a blank check company. at the 2023-03-16 meeting.","evidence_excerpt":"Advisory Governance Proposal D: A proposal to provide that shareholders will not be permitted to act by written resolution in lieu of holding a meeting of shareholders; and to eliminate provisions specific to its status as a blank check company. The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,359,773 548,090 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"cc64d20227aca025a02bab3498672091b5c2b7ba","claim":"Zura Bio Ltd shareholders approved Binding Organizational Documents Proposal B: A proposal to change the post-Business Combination corporate name from \"JATT Acquisition Corp\" to \"Zura Bio Limited,\" to make the post-Business Combination company's corporate existence perpetual and to eliminate provisions specific to its status as a bla at the 2023-03-16 meeting.","evidence_excerpt":"Binding Organizational Documents Proposal B: A proposal to change the post-Business Combination corporate name from \"JATT Acquisition Corp\" to \"Zura Bio Limited,\" to make the post-Business Combination company's corporate existence perpetual and to eliminate provisions specific to its status as a blank check company . The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,903,764 4,099 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"ccde63fa7ea30943138e63743971ee953f276a8b","claim":"Zura Bio Ltd shareholders approved A proposal to approve and adopt the Business Combination Agreement. at the 2023-03-16 meeting.","evidence_excerpt":"The Business Combination Proposal A proposal to approve and adopt the Business Combination Agreement. The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,903,764 4,099 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"f93e8fe32ccb6009e48f5925af0065c1527ae572","claim":"Zura Bio Ltd shareholders approved Advisory Governance Proposal A: A proposal to provide that subject to the rights of any holders of preferred shares to appoint directors, the number of directors that shall constitute the board shall be as determined from time to time exclusively by the Company board. at the 2023-03-16 meeting.","evidence_excerpt":"Advisory Governance Proposal A: A proposal to provide that subject to the rights of any holders of preferred shares to appoint directors, the number of directors that shall constitute the board shall be as determined from time to time exclusively by the Company board. The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 4,903,764 4,099 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}